Total Payments
$9,721
2024 Payments
$3,472
Companies
70
Transactions
465
Medicare Patients
2,023
Medicare Billing
$299,526
Payment Breakdown by Category
Food & Beverage$9,721 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,721 | 465 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,170 | 64 | $0 (2024) |
| UCB, Inc. | $768.03 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $549.66 | 35 | $0 (2024) |
| Biogen, Inc. | $487.32 | 19 | $0 (2024) |
| Genentech USA, Inc. | $401.47 | 17 | $0 (2024) |
| Amgen Inc. | $392.97 | 14 | $0 (2024) |
| Lundbeck LLC | $348.92 | 20 | $0 (2024) |
| Lilly USA, LLC | $312.78 | 17 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $305.55 | 12 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $289.33 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,472 | 168 | ABBVIE INC. ($638.10) |
| 2023 | $1,951 | 82 | AbbVie Inc. ($414.81) |
| 2022 | $1,071 | 53 | Merz Pharmaceuticals, LLC ($206.01) |
| 2021 | $406.85 | 20 | Biohaven Pharmaceuticals, Inc. ($120.66) |
| 2020 | $924.11 | 50 | Teva Pharmaceuticals USA, Inc. ($199.59) |
| 2019 | $1,167 | 60 | Novartis Pharmaceuticals Corporation ($173.74) |
| 2018 | $618.23 | 31 | Amgen Inc. ($161.90) |
| 2017 | $110.65 | 1 | Biogen, Inc. ($110.65) |
All Payment Transactions
465 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Neurology | ||||||
| 12/16/2024 | SpringWorks Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.24 | General |
| 12/13/2024 | Genentech USA, Inc. | Enspryng (Biological), Ocrevus, Ocrevus Zunovo | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.27 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.12 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Neurology | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: PAIN | ||||||
| 11/18/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $64.54 | General |
| Category: Neurology | ||||||
| 11/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Neurology | ||||||
| 11/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: Neurology | ||||||
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Immunology | ||||||
| 11/12/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 11/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 652 | 810 | $286,648 | $99,995 |
| 2022 | 9 | 254 | 355 | $103,135 | $39,144 |
| 2021 | 4 | 119 | 172 | $50,594 | $20,834 |
| 2020 | 16 | 998 | 1,329 | $833,570 | $139,553 |
Total Patients
2,023
Total Services
2,666
Medicare Billing
$299,526
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 61 | 67 | $64,475 | $20,162 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 186 | $44,835 | $17,964 | 40.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 79 | 79 | $30,407 | $13,236 | 43.5% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 31 | 32 | $16,304 | $6,948 | 42.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 52 | $20,913 | $6,818 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $15,834 | $6,487 | 41.0% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 25 | 25 | $21,422 | $5,636 | 26.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 53 | $11,627 | $4,850 | 41.7% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 29 | 31 | $9,386 | $3,157 | 33.6% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 34 | 59 | $9,477 | $2,891 | 30.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $6,968 | $2,811 | 40.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 18 | 18 | $9,521 | $2,397 | 25.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 23 | 31 | $6,956 | $2,253 | 32.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 13 | 13 | $7,937 | $2,163 | 27.3% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 37 | 50 | $7,236 | $1,328 | 18.4% |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | Office | 2023 | 11 | 11 | $1,733 | $586.63 | 33.8% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 30 | 31 | $1,616 | $306.23 | 19.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 57 | $22,846 | $8,943 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 85 | $22,451 | $8,101 | 36.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 79 | $16,340 | $6,467 | 39.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 13 | 14 | $11,061 | $4,372 | 39.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $9,435 | $3,497 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $8,171 | $3,058 | 37.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 17 | $6,261 | $2,210 | 35.3% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 13 | 27 | $3,759 | $1,430 | 38.1% |
About Dr. Yu Zhao, MD
Dr. Yu Zhao, MD is a Neurology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1992148977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yu Zhao, MD has received a total of $9,721 in payments from pharmaceutical and medical device companies, with $3,472 received in 2024. These payments were reported across 465 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($9,721).
As a Medicare-enrolled provider, Zhao has provided services to 2,023 Medicare beneficiaries, totaling 2,666 services with total Medicare billing of $299,526. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Plano, TX
- Active Since 04/09/2013
- Last Updated 12/28/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1992148977
Products in Payments
- UBRELVY (Drug) $516.76
- QULIPTA (Drug) $476.60
- NURTEC ODT (Drug) $344.79
- TYSABRI (Biological) $333.80
- Enspryng (Biological) $323.58
- Aimovig (Biological) $294.35
- Xeomin (Biological) $289.33
- Rystiggo (Drug) $259.39
- BOTOX (Biological) $244.94
- VYEPTI (Biological) $236.52
- Briviact (Drug) $233.50
- AIMOVIG (Biological) $198.27
- KESIMPTA (Drug) $197.02
- AUSTEDO (Drug) $164.57
- VALTOCO (Drug) $163.66
- ACTHAR (Biological) $163.52
- Leqembi (Drug) $163.40
- ZEPOSIA (Drug) $161.27
- APTIOM (Drug) $139.49
- RYTARY (Drug) $136.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Plano
Annette Okai, Md, MD
Neurology — Payments: $1.2M
Neurology $1.2M
Dr. Brian Sorin, M.d, M.D
Neurology — Payments: $65,471
Neurology $65,471
Parita Bhuva, M.d, M.D
Neurology — Payments: $55,398
Neurology $55,398
Dr. Wayne Bauknight, M.d, M.D
Neurology — Payments: $50,019
Neurology $50,019
Dr. Charisse Barta, M.d, M.D
Neurology — Payments: $24,290
Neurology $24,290
Mrs. Shari Rosen Schmidt, Md, MD
Neurology — Payments: $23,989
Neurology $23,989